ఎండోర్ఫిన్లో మెదడు మరియు వెన్నుపాము మరియు ఇతర ప్రదేశాలలో సంభవించే లక్షణాలు ఉన్నాయి,

enkephalins's Usage Examples:

scientific conference in May 1974, and published the structures of the two enkephalins in 1975.

that the NDE can be explained by the release of endorphins and enkephalins in the brain.

The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor.

found to inhibit the enzymatic degradation of oxytocin, vasopressin, enkephalins, and various other peptides and compounds.

The enkephalins are considered to be the primary endogenous ligands.

These drugs mimic three classes of endorphins, such as endomorphins, enkephalins, and dynorphins.

They isolated "enkephalins" (from the Greek εγκέφαλος, cerebrum) from pig brain, identified as Met-enkephalin.

It works by stopping the normal breakup of enkephalins, natural pain-killing opioids in the spinal cord.

The μ-opioid receptors (MOR) are a class of opioid receptors with a high affinity for enkephalins and beta-endorphin, but a low affinity for dynorphins.

Biphalin is a dimeric enkephalin endogenous peptide (Tyr-D-Ala-Gly-Phe-NH)2 composed of two tetrapeptides derived from enkephalins, connected "tail-to-tail".

Whereas CPA6 is capable of converting the enkephalins and neurotensin into inactive forms, it can convert the inactive angiotensin.

The endogenous opioids are dynorphins, enkephalins, endorphins.

It prevents the degradation of endogenous enkephalins by acting as an enkephalinase inhibitor.